home / stock / bngo / bngo news


BNGO News and Press, Bionano Genomics Inc. From 02/25/21

Stock Information

Company Name: Bionano Genomics Inc.
Stock Symbol: BNGO
Market: NASDAQ
Website: bionanogenomics.com

Menu

BNGO BNGO Quote BNGO Short BNGO News BNGO Articles BNGO Message Board
Get BNGO Alerts

News, Short Squeeze, Breakout and More Instantly...

BNGO - Bionano's Saphyr Data Prove Essential in Creating the Most Comprehensive, Ethnically Diverse Collection of Genome Variation Ever Completed

SAN DIEGO, Feb. 25, 2021 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) announced the publication in Science of a study by the Human Genome Structural Variation Consortium (HGSVC) that used a combination of advanced sequencing and optical genome mapping (OGM) with Saphyr to a...

BNGO - The Brave New Genomic World

Illumina and its short reading technology pushed the sequencing costs down during the last decade. Long reads and artificial intelligence are improving the sequencing and will likely keep driving the costs lower. Several companies are building business models around these technolo...

BNGO - Are These Top Health Care Stocks Worth Watching Ahead Of March?

Looking For The Best Health Care Stocks To Watch Right Now? 4 Names To Know You can’t deny that health care is a vital industry in the world we live in today. Similarly, health care stocks have and will likely continue to fill the same role in the stock market. With all e...

BNGO - Bionano Publishes Method for Identifying Genes Likely to Cause Neurological Diseases Based on a Model Developed by Lineagen to Improve Interpretation of Variants of Unknown Significance

SAN DIEGO, Feb. 22, 2021 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) announced the publication of a study by its Lineagen team that describes the first genome-wide model to assess and score nearly all protein-coding genes based on their likelihood to cause central nervous syst...

BNGO - Is It Too Late to Buy Bionano Genomics Stock?

Bionano Genomics (NASDAQ: BNGO) has certainly created a buzz in 2021. It's one of the top 100 most-popular stocks on Robinhood. Bionano's shares have skyrocketed more than 340% so far this year. With such a massive gain in such a short period, it's natural for investors to wonde...

BNGO - Busting Options Myths And Improving Expected Value: Reduce Worry Without Having To Guess

We propose a method for selling options that defies many myths around options selling. We analyzed options prices using statistical modelling and calculus to improve the "expected value" of trading versus conventional principles. Trades based on the criteria below are likely to wi...

BNGO - Is BioNano Genomics Stock a Buy?

Even if you've never had to analyze a genome yourself, you'll probably agree that they're quite complicated. But what would you do if you did need to analyze a genome to diagnose a patient or solve a key scientific question in the course of research? If you don't have an answer to this ...

BNGO - Bionano Genomics shares hit all-time high, spiking nearly 23%

Shares of Bionano Genomics (BNGO) have hit an all-time high this afternoon, breaking the $14 barrier for the first time.In the past 30 days, shares have more than doubled, up 106%.Today alone, shares are up 22.8% to $14.37 in afternoon trading.An article published in InvestorPl...

BNGO - Bionano Genomics to Present at the BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference

SAN DIEGO, Feb. 11, 2021 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) announced today that company management will present virtually at the BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference. Erik Holmlin, PhD, Bionano’s Chief Executive Officer,...

BNGO - Method for Solid Tumor Analysis with Saphyr Published by Penn State Institute for Personalized Medicine, Opening Largest Oncology Market to Optical Genome Mapping

SAN DIEGO, Feb. 11, 2021 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO), announced the publication of a method for using optical genome mapping (OGM) to identify structural variants (SVs) that drive cancer in a wide variety of solid tumor samples. The study, led by Dr. James Broa...

Previous 10 Next 10